Top 13 Quotes by Kathy Giusti

Although not yet routine, many cancer centers have the technology to sequence some or all of a patient's cancer genome. This can provide massive amounts of valuable information about your cancer, including whether you have genetic mutations and other abnormalities for which new drugs are available.

In 15 years, we've raised $225 million, sequenced the myeloma genome, and opened 45 trials of 23 drugs - six approved by the FDA - which have doubled the life span of multiple myeloma patients. I've taken both Velcade and Revlimid, which we helped develop.

I'm happy to say that I am in remission. That R word is something critically important to cancer patients, especially in a disease like myeloma. But I never lose sight of the fact that there is another R word called relapse.

Every time I go back to the Dana-Farber Cancer Institute to wait for my test results, and I wonder if I've relapsed or if I'm doing okay, I don't think about my company. I'm proud of everything we've done, but at the end of the day, it comes back to family. I'm still a wife, a mom, a sister - all of those things.

I quickly discovered that scientists go where the funding is, so I knew I had to start a research foundation. If you don't raise money and provide research grants, you'll never attract scientists, and if scientists aren't working on a cure, there isn't going to be a cure.